Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States

Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States

Abstract Background Although canakinumab has demonstrated efficacy in multiple trials in patients with periodic fever syndromes (PFS), the evidence on initiation of canakinumab among PFS patients in real world setting is not well understood. We aimed to characterize the reasons for canakinumab initi...

Full description

Bibliographic Details
Main Authors: Peter Hur, Kathleen G. Lomax, Raluca Ionescu-Ittu, Ameur M. Manceur, Jipan Xie, Jordan Cammarota, Raju Gautam, Navneet Sanghera, Nina Kim, Alexei A. Grom
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Canakinumab
Cryopyrin-associated periodic fever syndrome
Familial Mediterranean fever
Hyperimmunoglobulin D syndrome
Mevalonate kinase deficiency
Real world
Online Access:https://doi.org/10.1186/s12969-021-00605-2

Internet

https://doi.org/10.1186/s12969-021-00605-2

Similar Items